Panbela Therapeutics, Inc. (OTCMKTS:PBLA – Get Free Report)’s share price passed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $0.01 and traded as low as $0.0002. Panbela Therapeutics shares last traded at $0.0002, with a volume of 348 shares.
Panbela Therapeutics Price Performance
The firm’s 50 day moving average is $0.01 and its 200 day moving average is $0.01.
Panbela Therapeutics Company Profile
Panbela Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer and other serious diseases. The company’s research has centered on treatments that target polyamine metabolism, a biological process associated with tumor growth and cancer progression. Panbela’s lead investigational product has been ivospemin, formerly known as SBP-101, which has been studied in combination with standard treatments for pancreatic ductal adenocarcinoma and other solid tumors. The company has also pursued eflornithine-based programs, including combinations intended to support cancer treatment and prevention strategies.
Recommended Stories
- Five stocks we like better than Panbela Therapeutics
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Panbela Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Panbela Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
